§ Funding Round
Series A funding round for New Amsterdam Pharma raising $190M in January 2021
Series A funding round for New Amsterdam Pharma raising $190M in January 2021
| Investor | Firm Type | Partner |
|---|---|---|
Ascendant BioCapitalLEAD | — | — |
ForbionLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Angel | Peter Thiel | |
BVF Partners | — | — |
| Organization | — | |
Janus Henderson Investors | — | — |
| Organization | — | |
Kaiser Permanente | — | — |
LSP | — | — |
| Organization | — | |
jason dingesLEAD | Angel | jason dinges |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$190M
Top Valuation
-
New Amsterdam Pharma raised $190M in a Series A round.
The round was announced on 01/01/21.
The round was led by Ascendant BioCapital, Forbion, jason dinges.
